Replies to post #33303 on Anavex Life Sciences Corp (AVXL)

[Bman49ers]

That's not what Phase 2a is designed to do. AVXL achieved their primary endpoints and are moving on. News for Phase 2b/3 will be out before the end of the year. Also they are ahead of schedule.as enrollment finished early.

[hugh_jackoman]

When they do and it's looking very likely the stock will be much much higher.

[dayneyus]

Standby, you will soon get the rest of the story.


"We are encouraged by the preliminary safety and efficacy data. We look forward to continuing with PART B of the Phase 2a trial and expect to provide data updates at 12 week, 26 week, 38 week and 52 week time points," said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

"While we remain focused on Alzheimer's, the remarkably fast onset of clinical effect of ANAVEX 2-73 increases our options to potentially pursue additional indications for diseases characterized by working memory impairment and may enable clinical trials to be completed within shorter time frames."